Barinthus Biotherapeutics (BRNS) Return on Sales (2020 - 2025)
Historic Return on Sales for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to 239.58%.
- Barinthus Biotherapeutics' Return on Sales fell 2390300.0% to 239.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 239.58%, marking a year-over-year decrease of 2357100.0%. This contributed to the annual value of 4.09% for FY2024, which is 874900.0% up from last year.
- According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Return on Sales is 239.58%, which was down 2390300.0% from 21126.0% recorded in Q2 2025.
- In the past 5 years, Barinthus Biotherapeutics' Return on Sales registered a high of 16837.0% during Q4 2021, and its lowest value of 21126.0% during Q2 2025.
- Over the past 5 years, Barinthus Biotherapeutics' median Return on Sales value was 39.83% (recorded in 2021), while the average stood at 324.11%.
- In the last 5 years, Barinthus Biotherapeutics' Return on Sales surged by 168716400bps in 2021 and then crashed by -168402800bps in 2022.
- Quarter analysis of 5 years shows Barinthus Biotherapeutics' Return on Sales stood at 16837.0% in 2021, then plummeted by -100bps to 3.28% in 2022, then plummeted by -2694bps to 91.58% in 2023, then surged by 96bps to 4.09% in 2024, then tumbled by -5761bps to 239.58% in 2025.
- Its Return on Sales stands at 239.58% for Q3 2025, versus 21126.0% for Q2 2025 and 62.21% for Q1 2025.